HPRT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.81006999999678E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.957700E-02
Normal-vs-Stage2
1.69394999999239E-05
Normal-vs-Stage3
3.315800E-01
Normal-vs-Stage4
1.374790E-01
Stage1-vs-Stage2
8.167000E-01
Stage1-vs-Stage3
5.869000E-01
Stage1-vs-Stage4
9.904600E-01
Stage2-vs-Stage3
7.313200E-01
Stage2-vs-Stage4
8.411200E-01
Stage3-vs-Stage4
6.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.07340000005318E-06
Normal-vs-AfricanAmerican
2.109200E-01
Normal-vs-Asian
5.607900E-02
Caucasian-vs-AfricanAmerican
5.452800E-01
Caucasian-vs-Asian
9.838800E-01
AfricanAmerican-vs-Asian
6.080400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.37339999997754E-06
Normal-vs-Female
2.95510000003496E-06
Male-vs-Female
9.240000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.467000E-01
Normal-vs-Age(41-60Yrs)
3.2037999997403E-07
Normal-vs-Age(61-80Yrs)
2.20779999999809E-05
Normal-vs-Age(81-100Yrs)
4.677600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.089000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.302400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.103400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.523830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.652800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.975900E-03
Normal-vs-Daily Drinker
1.040190E-02
Normal-vs-Weekly Drinker
8.231700E-02
Normal-vs-Occasional Drinker
2.356400E-04
Normal-vs-Social Drinker
7.447800E-02
Non Drinker-vs-Daily Drinker
5.471400E-01
Non Drinker-vs-Weekly Drinker
9.642400E-01
Non Drinker-vs-Occasional Drinker
1.683990E-01
Non Drinker-vs-Social Drinker
3.856000E-01
Daily Drinker-vs-Weekly Drinker
6.813400E-01
Daily Drinker-vs-Occasional Drinker
4.710300E-02
Daily Drinker-vs-Social Drinker
7.014800E-01
Weekly Drinker-vs-Occasional Drinker
2.816000E-01
Weekly Drinker-vs-Social Drinker
5.323000E-01
Occasional Drinker-vs-Social Drinker
3.707900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.433200E-01
Normal-vs-Grade 2
2.138200E-01
Normal-vs-Grade 3
2.607400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.788200E-01
Grade 1-vs-Grade 3
9.044000E-01
Grade 1-vs-Grade 4
4.433200E-01
Grade 2-vs-Grade 3
5.206400E-01
Grade 2-vs-Grade 4
2.138200E-01
Grade 3-vs-Grade 4
2.607400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.942400E-03
Normal-vs-NonDiabetic
2.54879999994628E-07
Diabetic-vs-NonDiabetic
1.366780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.048200E-02
Normal-vs-NoPancreatitis
7.63740000020441E-07
Pancreatitis-vs-NoPancreatitis
5.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.82350000002651E-06
Normal-vs-N1
1.9106399999913E-05
N0-vs-N1
1.862950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.114210E-01
Normal-vs-TP53-NonMutant
4.536200E-01
TP53-Mutant-vs-TP53-NonMutant
1.584390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
